| Literature DB >> 35766801 |
Lydia B Zablotska1, Rachel S D Lane2, Kristi Randhawa2.
Abstract
BACKGROUND: The authors assessed the association between radon decay products (RDP) exposure and histologic types of incident lung cancer in a cohort of 16,752 (91.6% male) Eldorado uranium workers who were first employed from 1932 to 1980 and were followed through 1969-1999.Entities:
Keywords: adenocarcinoma; histologic type; lung carcinoma; radiation; radon decay products; small cell; squamous cell
Mesh:
Substances:
Year: 2022 PMID: 35766801 PMCID: PMC9545258 DOI: 10.1002/cncr.34351
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.921
FIGURE 1STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) flow diagram.
Basic Characteristics of the Eldorado Incidence Cohort, 1969–1999
| Characteristic | No. of men (%) | No. of females (%) |
|---|---|---|
| Total | 15,351 (91.6) | 1401 (8.4) |
| Subcohort | ||
| Port Radium | 2677 (17.4) | 246 (17.6) |
| Beaverlodge | 9233 (60.1) | 551 (39.3) |
| Port Hope | 2411 (15.7) | 337 (24.1) |
| Other sites | 1030 (6.7) | 267 (19.1) |
| Birth cohort | ||
| 1876–1910 | 933 (6.1) | 45 (3.2) |
| 1910–1919 | 1521 (9.9) | 96 (6.8) |
| 1920–1929 | 3604 (23.5) | 265 (18.9) |
| 1930–1939 | 3555 (23.2) | 277 (19.8) |
| 1940–1949 | 2529 (16.5) | 249 (17.8) |
| 1950–1959 | 2753 (18.0) | 361 (25.7) |
| 1960–1965 | 456 (3.0) | 108 (7.7) |
| Year first employed | ||
| 1933–1939 | 43 (0.3) | 0 (0.0) |
| 1940–1949 | 2010 (13.1) | 196 (14.0) |
| 1950–1959 | 5725 (37.3) | 351 (25.0) |
| 1960–1969 | 2612 (17.0) | 164 (11.7) |
| 1970–1981 | 4961 (32.3) | 690 (49.3) |
| Total person‐years | 367,253 | 34,646 |
| Cumulative RDP exposure: Mean ± SD [range], WLM | 106.14 ± 239.92 [0.00–2727.70] | 3.72 ± 9.34 [0.00–67.60] |
| Port Radium | 230.02 ± 381.17 [0.00–2727.70] | 1.87 ± 10.82 [0.00–67.60] |
| Beaverlodge | 81.11 ± 47.35 [0.00–1616.80] | 0.93 ± 2.55 [0.00–16.78] |
| Port Hope | 18.74 ± 50.42 [0.00–590.32] | 7.36 ± 11.81 [0.00–62.7]) |
| Other sites | 5.69 ± 40.81 [0.00–984.23] | 0.07 ± 0.25 [0.00–1.70] |
| Cumulative γ‐ray dose: Mean ± SD [range], mSv | 62.39 ± 163.13 [0.00–2920.90] | 26.01 ± 69.46 [0.00–619.84] |
| Port Radium | 49.89 ± 91.67 [0.00–1076.10] | 17.51 ± 99.26 [0.00–619.84] |
| Beaverlodge | 32.31 ± 42.53 [0.00–393.10] | 1.55 ± 3.58 [0.00–22.19] |
| Port Hope | 169.00 ± 331.11 [0.00–2920.90] | 53.28 ± 83.95 [0.00–464.74] |
| Other sites | 17.09 ± 36.75 [0.00–250.32] | 1.57 ± 3.84 [0.00–30.94] |
| Cumulative total dose to the lung: Mean ± SD [range], mSv | 931.65 ± 1990.90 [0.00–22,680.00] | 56.49 ± 143.14 [0.00–1173.50] |
Abbreviations: mSv, millisieverts; RDP, radon decay products; SD, standard deviation; WLM, working level months.
Weighted by person‐years and lagged by 5 years.
Weighted by person‐years and lagged by 5 years.
Distribution of Lung Cancer by Histologic Type and Subcohort: Eldorado Incidence Cohort, Men, 1969–1999
| Histologic type of lung cancer | Subcohort, no. (%) | ||||
|---|---|---|---|---|---|
| Port Radium | Beaverlodge | Port Hope | Other Sites | Total | |
| Squamous cell | 59 (32.4) | 110 (37.0) | 27 (25.5) | 3 (33.3) | 199 (33.5) |
| Small cell | 34 (18.7) | 52 (17.5) | 9 (8.5) | 2 (22.2) | 97 (16.3) |
| Adenocarcinoma | 34 (18.7) | 47 (15.8) | 22 (20.8) | 0 (0.0) | 103 (17.3) |
| Other types | 55 (30.2) | 88 (29.6) | 48 (45.3) | 4 (44.4) | 195 (32.8) |
| Total | 182 | 297 | 106 | 9 | 594 |
The p value of χ = .04 for four histologic types of lung cancer in four subcohorts and .02 for four types in the three main subcohorts.
For International Classification of Diseases for Oncology (ICDO) codes for each histological type, see Table S1.
FIGURE 2Categorical relative risks (95% confidence intervals) and fitted exposure‐response lines for lung cancer, Eldorado incidence cohort, men, 1969–1999. (A) Full cumulative RDP exposure range; and (B) Cumulative RDP exposures restricted to <100 WLM. RDP indicates radon decay products; RR, relative risk; WLM, working level months.
Standardized incidence ratios of lung cancer by subcohort, histologic type, and cumulative radon decay product exposure categories: Eldorado incidence cohort, men, 1969–1999
| Variable | No. observed | No. expected | SIR | 95% lower limit | 95% upper limit |
|
|---|---|---|---|---|---|---|
| Total | 594 | 510.23 | 1.16 | 1.07 | 1.26 | < .001 |
| Subcohort | ||||||
| Port Radium | 182 | 147.37 | 1.23 | 1.06 | 1.41 | .01 |
| Beaverlodge | 297 | 249.38 | 1.19 | 1.06 | 1.33 | .01 |
| Port Hope | 106 | 93.38 | 1.14 | 0.92 | 1.35 | .22 |
| Other sites | 9 | 20.11 | 0.45 | 0.16 | 0.74 | < .001 |
| Histologic type of lung cancer | ||||||
| Squamous cell | 130 | 98.26 | 1.32 | 1.10 | 1.55 | < .001 |
| Small cell | 56 | 43.78 | 1.28 | 0.94 | 1.61 | .10 |
| Adenocarcinoma | 68 | 77.94 | 0.87 | 0.67 | 1.08 | .23 |
| Other types | 95 | 111.62 | 0.85 | 0.68 | 1.02 | .09 |
| Cumulative RDP exposure, WLM | ||||||
| 0–99 | 431 | 425.11 | 1.01 | 0.92 | 1.11 | .78 |
| 100–299 | 81 | 49.38 | 1.64 | 1.28 | 2.00 | < .001 |
| ≥300 | 82 | 35.75 | 2.29 | 1.80 | 2.79 | < .001 |
Abbreviations: CCDB, Canadian Cancer Data Base; RDP, radon decay products; SIR, standardized incidence ratio; WLM, working level months.
The number of observed cases reflects the incidence of newly diagnosed cancer cases in which a single individual can contribute only one case of cancer.
Adjusted for attained age and calendar year at risk by stratification. The number of expected cases is based on the incidence of newly diagnosed cancer cases in Canada in which a single individual can contribute more than one case of cancer.
Analyses are based on the data for 1985–1999, when incidence rates by lung cancer histologic types are available in the CCDB.
Excess relative risk estimates of radon decay product‐associated lung cancer from the simple linear model: Eldorado incidence cohort, men, 1969–1999
| Categorical effect modifier | No. of cases | Mean cumulative RDP exposure, WLM | ERR per 100 WLM (95% CI) |
| Deviance |
|---|---|---|---|---|---|
| All subjects | 594 | 106.14 | 0.61 (0.39–0.91) | < .001 | 6071.02 |
| Subcohort | |||||
| Port Radium | 182 | 230.02 | 0.38 (0.21–0.66) | .093 | 6009.06 |
| Beaverlodge | 297 | 81.11 | 0.93 (0.48–1.61) | ||
| Port Hope | 106 | 18.74 | 1.43 (−0.10, 6.05) | ||
| Histologic type | |||||
| Squamous cell | 199 | 210.77 | 0.65 (0.31–1.24) | .144 | 2247.23 |
| Small cell | 97 | 138.05 | 0.51 (0.14–1.32) | 1266.57 | |
| Adenocarcinoma | 103 | 101.24 | 0.45 (0.11–1.19) | 1266.57 | |
| Other types | 195 | 121.90 | 0.93 (0.41–1.90) | 2220.35 |
Abbreviations: CI, confidence interval; ERR/100 WLM, excess relative risk per 100 working level months; RDP, radon decay products; WLM, working level months.
Adjusted for subcohort, attained age, calendar year at risk, and duration of employment by stratification.
Based on analysis including workers from other sites; baseline model, unadjusted for effect modifiers of risk.
The p value from the likelihood ratio test comparing models with and without the exposure variable.
Based on analysis excluding workers from other sites (2 degrees of freedom).
The p value for effect modification.
Based on analysis including subjects with known histologic type of lung cancer and those with no lung cancer.
The Biological Effects of Ionizing Radiation (BEIR) VI Interaction Model for Lung Cancer by Cumulative Radon Decay Product Exposure: Eldorado Incidence Cohort, Men
| Parameter | “Exposure‐age‐concentration” model | “Exposure‐age‐duration” model | ||||
|---|---|---|---|---|---|---|
| No. of cases | Parameter estimate (95% CI) |
| No. of cases | Parameter estimate (95% CI) |
| |
| Cumulative RDP exposure | 594 | 27.08 (10.18–59.25) | < .001 | 594 | 6.64 (−0.10, 20.93) | < .001 |
| Time‐since‐exposure windows, years | ||||||
| WLM 5–14 previously | 1.00 | 1.00 | ||||
| WLM 15–24 previously | 0.28 | < .001 | 0.11 | < .001 | ||
| WLM ≥25 previously | 0.08 | < .001 | 0.02 | < .001 | ||
| Exposure rate, WL | ||||||
| <0.5 | 248 | 1.00 | .003 | |||
| 0.5–0.9 | 77 | 0.37 (0.18–0.76) | ||||
| 1.0–2.9 | 125 | 0.32 (0.17–0.59) | ||||
| 3.0–53.9 | 144 | 0.15 (0.07–0.31) | ||||
| Exposure duration, years | ||||||
| <0.5 | 208 | 1.00 | .017 | |||
| 0.5–2.49 | 176 | 1.10 (0.32–3.81) | ||||
| 2.5–4.9 | 62 | 0.98 (0.22–4.42) | ||||
| 5.0–14.9 | 99 | 1.40 (0.36–5.49) | ||||
| 15–46 | 49 | 3.76 (0.44–32.15) | ||||
| Attained age, years | ||||||
| <55 | 110 | 1.00 | .001 | 110 | 1.00 | < .001 |
| 55–64 | 248 | 2.33 (1.24–4.36) | 248 | 1.84 (0.91–3.72) | ||
| 65–98 | 236 | 1.19 (0.53–2.67) | 236 | 0.76 (0.30–1.94) | ||
Abbreviations: CI, confidence interval; ERR/100 WLM, excess relative risk per 100 working level months; RDP, radon decay products; WL, working level; WLM, working level months.
BEIR VI interaction model (“Exposure‐age‐concentration”) for lung cancer by cumulative RDP exposure, Eldorado Incidence Cohort, men, 1969–1999.
The number of cases in the incidence analysis based on the earliest cancer diagnosis for which each individual could contribute at most one cancer.
ERR/100 WLM for cumulative RDP exposure and relative risks for time since exposure, exposure rate, and attained age variables.
Adjusted for subcohort, attained age, calendar year at risk, and duration of employment by stratification.
The p value of the test of heterogeneity of category‐specific parameter estimates.
BEIR VI interaction model (“Exposure‐age‐duration”) for lung cancer by cumulative RDP exposure, Eldorado Incidence Cohort, men, 1950–1999.
Cumulative RDP exposure lagged by 5 years.
The p value for the difference between the specified time‐since‐exposure window and the earliest time‐since‐exposure window (5–14 years).
FIGURE 3Correlation between cumulative unlagged RDP exposures and γ‐ray doses, Eldorado incidence cohort, men 1969–1999. Scatterplots using a log10 scale for both axes. mGy indicates milligrays; RDP, radon decay products; WLM, working level months.